Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
- Conditions
- Sarcoma
- Registration Number
- NCT00002993
- Lead Sponsor
- Gynecologic Oncology Group
- Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with mitomycin, doxorubicin, and cisplatin in treating patients with recurrent or advanced cancer of the uterus.
- Detailed Description
OBJECTIVES: I. Estimate the antitumor activity of the combination of mitomycin, doxorubicin, and cisplatin (MAP) in patients with recurrent or advanced uterine sarcomas. II. Determine the nature and degree of toxicity of MAP chemotherapy in this cohort of patients.
OUTLINE: Patients receive IV doxorubicin, mitomycin, and cisplatin over 3 hours once every 3 weeks, for a minimum of 1 course. Patients who have complete response, partial response, or stable disease will continue for at least 3 courses. If side effects are not severe, patients may remain on the study regimen at the investigator's discretion for a maximum of 6 courses. All patients are followed until death.
PROJECTED ACCRUAL: The first stage of accrual is anticipated to accrue 20 evaluable patients in approximately 12 months. If indicated, a second stage will accrue approximately 10 evaluable patients.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 30
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (54)
Arthur G. James Cancer Hospital - Ohio State University
🇺🇸Columbus, Ohio, United States
Jonsson Comprehensive Cancer Center, UCLA
🇺🇸Los Angeles, California, United States
University of Chicago Cancer Research Center
🇺🇸Chicago, Illinois, United States
Pennsylvania Hospital
🇺🇸Philadelphia, Pennsylvania, United States
Ireland Cancer Center
🇺🇸Cleveland, Ohio, United States
Medicine Branch
🇺🇸Bethesda, Maryland, United States
Rush-Presbyterian-St. Luke's Medical Center
🇺🇸Chicago, Illinois, United States
Vincent T. Lombardi Cancer Research Center, Georgetown University
🇺🇸Washington, District of Columbia, United States
USC/Norris Comprehensive Cancer Center
🇺🇸Los Angeles, California, United States
Johns Hopkins Oncology Center
🇺🇸Baltimore, Maryland, United States
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
🇺🇸Winston-Salem, North Carolina, United States
University of Iowa Hospitals and Clinics
🇺🇸Iowa City, Iowa, United States
Chao Family Comprehensive Cancer Center
🇺🇸Orange, California, United States
H. Lee Moffitt Cancer Center and Research Institute
🇺🇸Tampa, Florida, United States
Radiation Oncology Branch
🇺🇸Bethesda, Maryland, United States
University of Alabama Comprehensive Cancer Center
🇺🇸Birmingham, Alabama, United States
Albert B. Chandler Medical Center, University of Kentucky
🇺🇸Lexington, Kentucky, United States
Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States
Indiana University Cancer Center
🇺🇸Indianapolis, Indiana, United States
University of Texas - MD Anderson Cancer Center
🇺🇸Houston, Texas, United States
University of Minnesota Cancer Center
🇺🇸Minneapolis, Minnesota, United States
CCOP - Southern Nevada Cancer Research Foundation
🇺🇸Las Vegas, Nevada, United States
Barrett Cancer Center, The University Hospital
🇺🇸Cincinnati, Ohio, United States
Barbara Ann Karmanos Cancer Institute
🇺🇸Detroit, Michigan, United States
CCOP - Ann Arbor Regional
🇺🇸Ann Arbor, Michigan, United States
University of Massachusetts Memorial Medical Center
🇺🇸Worcester, Massachusetts, United States
University of Rochester Cancer Center
🇺🇸Rochester, New York, United States
State University of New York Health Science Center at Brooklyn
🇺🇸Brooklyn, New York, United States
University of Oklahoma College of Medicine
🇺🇸Oklahoma City, Oklahoma, United States
Cleveland Clinic Cancer Center
🇺🇸Cleveland, Ohio, United States
University of Pennsylvania Cancer Center
🇺🇸Philadelphia, Pennsylvania, United States
Simmons Cancer Center - Dallas
🇺🇸Dallas, Texas, United States
CCOP - Upstate Carolina
🇺🇸Spartanburg, South Carolina, United States
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States
Tacoma General Hospital
🇺🇸Tacoma, Washington, United States
University of Washington Medical Center
🇺🇸Seattle, Washington, United States
MBCCOP - Hawaii
🇺🇸Honolulu, Hawaii, United States
Lineberger Comprehensive Cancer Center, UNC
🇺🇸Chapel Hill, North Carolina, United States
Women's Cancer Center
🇺🇸Palo Alto, California, United States
Cooper Hospital/University Medical Center
🇺🇸Camden, New Jersey, United States
Walter Reed Army Medical Center
🇺🇸Washington, District of Columbia, United States
University of Colorado Cancer Center
🇺🇸Denver, Colorado, United States
Emory University Hospital - Atlanta
🇺🇸Atlanta, Georgia, United States
State University of New York Health Sciences Center - Stony Brook
🇺🇸Stony Brook, New York, United States
Abington Memorial Hospital
🇺🇸Abington, Pennsylvania, United States
Cancer Center of Albany Medical Center
🇺🇸Albany, New York, United States
Duke Comprehensive Cancer Center
🇺🇸Durham, North Carolina, United States
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
🇺🇸Philadelphia, Pennsylvania, United States
Milton S. Hershey Medical Center
🇺🇸Hershey, Pennsylvania, United States
Cancer Center, University of Virginia HSC
🇺🇸Charlottesville, Virginia, United States
University of Mississippi Medical Center
🇺🇸Jackson, Mississippi, United States
Memorial Sloan-Kettering Cancer Center
🇺🇸New York, New York, United States
North Shore University Hospital
🇺🇸Manhasset, New York, United States
Fox Chase Cancer Center
🇺🇸Philadelphia, Pennsylvania, United States